Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 8

Results For "Contract-Research"

81 News Found

Domestic growth to the fore as US weakness persists: ICICI Direct
News | October 19, 2021

Domestic growth to the fore as US weakness persists: ICICI Direct

ICICI Direct gives an update on the 12 companies that it has covered in the healthcare universe. A report


Sai Life Sciences presents its midterm report
News | October 11, 2021

Sai Life Sciences presents its midterm report

The company has enabled a transformation across three core areas with an investment target of US $ 150 million


Argenta acquires Klifovet to expand global footprint in animal health
Biotech | September 17, 2021

Argenta acquires Klifovet to expand global footprint in animal health

Klifovet’s client base comprises the world’s top animal health and nutrition companies as well as many promising startups


CRAMS to drive growth for Indian pharma industry: report
News | September 06, 2021

CRAMS to drive growth for Indian pharma industry: report

The global CRAMS segment is expected to clock 6.2% CAGR over CY21-26E to touch US $ 170 billion


Accutest enables NMPA approval for Qilu’s Abiraterone
Drug Approval | September 06, 2021

Accutest enables NMPA approval for Qilu’s Abiraterone

The bioequivalence study was conducted by Accutest Research India, one of the preferred CRO players in India


Vivo Bio Tech enters long-term contract with Bio E
Biotech | August 30, 2021

Vivo Bio Tech enters long-term contract with Bio E

The value of the contract is estimated to be between Rs 20-30 crores per year for the next three years


Sai Life Sciences is now a United Nations Global Compact (UNGC) signatory
News | August 26, 2021

Sai Life Sciences is now a United Nations Global Compact (UNGC) signatory

In the last two years, Sai Life Sciences has made significant investments and progress in advancing its sustainability agenda as part of its organizational transformation initiative


Strong show in domestic formulations business by Indian pharma in Q1FY22: Ind-Ra
News | August 26, 2021

Strong show in domestic formulations business by Indian pharma in Q1FY22: Ind-Ra

Domestic business was up 41.9% YoY and 27.7% QoQ


Sai Life Sciences opens discovery biology facility in Hyderabad
Drug Approval | August 19, 2021

Sai Life Sciences opens discovery biology facility in Hyderabad

The company's discovery services support a wide range of global innovator companies from start-ups to large pharma companies, across a diverse set of therapeutic areas including oncology, CNS, antivirals, and inflammation among others


Jubilant Pharmova posts Q4FY21 consolidated PAT of Rs. 213.90 Cr
News | June 05, 2021

Jubilant Pharmova posts Q4FY21 consolidated PAT of Rs. 213.90 Cr

The company is doubling its chemistry research capacity that should commission by Q2'FY22